1.
Clin Case Rep
; 9(7): e04513, 2021 Jul.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34322259
RESUMO
Most of the post-renal transplant patients are taking immunosuppressive medications, including calcineurin inhibitors, anti-proliferative agents, and steroids. This case series highlights the clinical characteristics and outcomes of eight post-renal transplant patients with severe COVID-19 infection admitted to the intensive care unit.
2.
Clin Case Rep
; 9(1): 148-152, 2021 Jan.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33489151
RESUMO
The authors urge clinicians to observe for early signs of CMV reactivation in patients presenting with gastrointestinal bleeding and intestinal perforation after receiving tocilizumab or other immunosuppressive therapy as a treatment for COVID 19. Early recognition of CMV infection and treatment will prevent life-threatening bleeding and mortality.